Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failure
- 30 November 1992
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 121 (5) , 822-825
- https://doi.org/10.1016/s0022-3476(05)81923-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot studyThe Journal of Pediatrics, 1992
- Factors limiting the erythropoietin response in rapidly growing infants with congenital nephrosis on a peritoneal dialysis regimen after nephrectomyThe Journal of Pediatrics, 1992
- Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurityThe Journal of Pediatrics, 1991
- Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot studyThe Journal of Pediatrics, 1991
- Age-Related Differences in Erythropoietic Response to Recombinant Human Erythropoietin: Comparison in Adult and Infant Rhesus MonkeysPediatric Research, 1990
- Abnormal iron distribution in infants of diabetic mothers: Spectrum and maternal antecedentsThe Journal of Pediatrics, 1990
- Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysisThe Journal of Pediatrics, 1989
- A system approach to pharmacodynamics I: Theoretical frameworkJournal of Pharmaceutical Sciences, 1988